BMS builds big in Texas; Regeneron backs would-be rival

BMS builds big in Texas; Regeneron backs would-be rival is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

PharmaVoice Staff · 2026-08-14

BMS reveals plans for a new manufacturing hub in Houston, and Regeneron invests in startup developing a Dupixent competitor.

Source: PharmaVoice